Skip to main content

Advertisement

Correction to: Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history

The original article was published in Translational Neurodegeneration 2019 8:2

Correction to: Transl Neurodegener (2019) 8:2

https://doi.org/10.1186/s40035-018-0142-8

In the original publication of this article [1], a numerical value in the sentence “The mean (SD) AAO was 43.92 years (9.24) for all subjects, with a significant difference between patients carrying mutations in exon 2 (n = 24, 46.83, 8.31) and exon 4 (n = 18, 37.75, 7.67) (p = 0.002).” is wrong. The true value in the parenthesis of exon 2 should be (n = 24, 46.63, 8.31).

Reference

  1. 1.

    Tang L, et al. Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history. Transl Neurodegener. 2019;8:2 https://doi.org/10.1186/s40035-018-0142-8.

Download references

Author information

Correspondence to Dong-sheng Fan.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article